drugset
drugset / Trial / NCT04039919

A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol

NCT04039919 ↗

Phase 1 Terminated 40 enrolled UCB Biopharma S.P.R.L.
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of the study is to evaluate the pharmacodynamic (PD) interaction between steady-steady treatment with padsevonil (PSL) and Ethanol and the pharmacokinetic (PK) interaction between stead-state treatment with PSL and cannabidiol (CBD).

Timeline

Start
2019-07-17
Primary completion
2020-05-22
Completion
2020-05-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Padsevonil Small molecule — —

Indications

No indication recorded.